Skip to main content
Allison Kurian, MD, Oncology, Palo Alto, CA

AllisonWalshKurianMDMSc

Oncology Palo Alto, CA

Breast Cancer, Cancer Genetics/Cancer Risk Assessment

Professor, Medicine - Oncology and Epidemiology & Population Health, Stanford University School of Medicine

Dr. Kurian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kurian's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Palo Alto, CA 94305
    Phone+1 650-723-4000

Education & Training

  • Stanford University School of Medicine
    Stanford University School of MedicineM.Sc., 2004 - 2006
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2002 - 2003
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2002
  • Harvard Medical School
    Harvard Medical SchoolClass of 1999
  • Stanford University
    Stanford UniversityB.A., 1991 - 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Risk-Reducing Salpingo-Oophorectomy with Breast Cancer Risk in Women with BRCA1 and BRCA2 Pathogenic Variants  
    Mary B Daly, Sarah Colonna, Saundra S Buys, Allison W Kurian, JAMA Oncology
  • Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer—Reply  
    Allison W Kurian, Steven J Katz, JAMA
  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing  
    William J Gradishar, Al B Benson, Massimo Cristofanilli, Allison W Kurian, Value in Health
  • Join now to see all

Lectures

  • Breast cancer treatment according to pathogenic variants in cancer susceptibility genes in a population-based cohort. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
  • Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • Genetic testing and results in population-based breast cancer patients and ovarian cancer patients. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Authored Content

  • From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingAugust 2018

Press Mentions

  • Genetic Tests Provide Treatment Opportunities and Confusion for Breast Cancer Patients
    Genetic Tests Provide Treatment Opportunities and Confusion for Breast Cancer PatientsOctober 21st, 2024
  • Many Breast Cancer Survivors with Indications for Genetic Testing Do Not Receive It
    Many Breast Cancer Survivors with Indications for Genetic Testing Do Not Receive ItJuly 24th, 2024
  • Antibiotics After Breast Cancer Linked to Poorer Survival, Stanford Medicine-Led Study Finds
    Antibiotics After Breast Cancer Linked to Poorer Survival, Stanford Medicine-Led Study FindsApril 18th, 2023
  • Join now to see all

Professional Memberships